Searle & Co. Buys Takeda Pharmaceutical Co, Invesco QQQ Trust Series 1, SPDR S&P 500, Sells Shire PLC, BioDelivery Sciences International Inc, TransMontaigne Partners LP

• New Purchases: TAK, QQQ, SPY, FEZ, DVY, IVV, 35OB, GLD, GPOR, ACHV, TMO, UTX, WMB, TGT, ATRS, AYTU, VGZ,
• Added Positions: AAPL, AMZN, RRC, MMM, DWDP, ADP, T, YUM, MDLZ, NEE, ABT, VZ,
• Reduced Positions: MO, GLOG, ET, STI, BANC,
• Sold Out: SHPG, BDSI, TLP, BGS, SRE, ATVI, MPC, OZM, CLF,

For the details of Searle & Co.'s stock buys and sells, go to https://www.gurufocus.com/guru/searle+%26+co./current-portfolio/portfolio

1. Exxon Mobil Corp (XOM) - 88,008 shares, 4.43% of the total portfolio. Shares added by 0.35%
2. Bank of America Corporation (BAC) - 208,960 shares, 3.59% of the total portfolio. Shares added by 0.34%
3. Johnson & Johnson (JNJ) - 38,110 shares, 3.32% of the total portfolio. Shares added by 0.63%
4. Bristol-Myers Squibb Company (BMY) - 90,050 shares, 2.68% of the total portfolio. Shares reduced by 0.6%
5. Microsoft Corp (MSFT) - 34,126 shares, 2.51% of the total portfolio.

Searle & Co. initiated holding in Takeda Pharmaceutical Co Ltd. The purchase prices were between $16.7 and $21.52, with an estimated average price of $20.07. The stock is now traded at around $18.26. The impact to a portfolio due to this purchase was 0.47%. The holding were 37,196 shares as of .

Searle & Co. initiated holding in Invesco QQQ Trust Series 1. The purchase prices were between $149.82 and $182.57, with an estimated average price of $169.41. The stock is now traded at around $187.92. The impact to a portfolio due to this purchase was 0.27%. The holding were 2,400 shares as of .

Searle & Co. initiated holding in SPDR S&P 500. The purchase prices were between $244.21 and $284.73, with an estimated average price of $271.34. The stock is now traded at around $290.27. The impact to a portfolio due to this purchase was 0.25%. The holding were 1,400 shares as of .

Searle & Co. initiated holding in SPDR DJ Euro STOXX 50 Etf. The purchase prices were between $32.68 and $37.47, with an estimated average price of $35.44. The stock is now traded at around $38.31. The impact to a portfolio due to this purchase was 0.24%. The holding were 3,000 shares as of .

Searle & Co. initiated holding in iShares Select Dividend ETF. The purchase prices were between $88.2 and $99.71, with an estimated average price of $95.67. The stock is now traded at around $100.06. The impact to a portfolio due to this purchase was 0.23%. The holding were 3,775 shares as of .

Searle & Co. initiated holding in iShares Core S&P 500. The purchase prices were between $245.43 and $286.57, with an estimated average price of $273.1. The stock is now traded at around $292.30. The impact to a portfolio due to this purchase was 0.2%. The holding were 1,108 shares as of .

Searle & Co. added to a holding in Amazon.com Inc by 25.68%. The purchase prices were between $1500.28 and $1819.26, with an estimated average price of $1661.42. The stock is now traded at around $1887.31. The impact to a portfolio due to this purchase was 0.06%. The holding were 279 shares as of .

Searle & Co. sold out a holding in Shire PLC. The sale prices were between $172.15 and $179.2, with an estimated average price of $176.08.

Searle & Co. sold out a holding in BioDelivery Sciences International Inc. The sale prices were between $3.65 and $5.3, with an estimated average price of $4.55.

Searle & Co. sold out a holding in TransMontaigne Partners LP. The sale prices were between $40.58 and $41.54, with an estimated average price of $41.04.

Searle & Co. sold out a holding in B&G Foods Inc. The sale prices were between $23.43 and $30.31, with an estimated average price of $26.26.

Searle & Co. sold out a holding in Sempra Energy. The sale prices were between $106.76 and $126.07, with an estimated average price of $117.55.

Searle & Co. sold out a holding in Activision Blizzard Inc. The sale prices were between $40.11 and $51.35, with an estimated average price of $45.26.